Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

BACKGROUND: The reciprocal fate decision of mesenchymal stem cells (MSCs) to either bone or adipocytes is determined by Wnt-related signaling and the glucagon-like peptide-1 receptor (GLP-1R). Azoramide, an ER stress alleviator, was reported to have an antidiabetic effect. In this study, we investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Banjun, Zhu, Zheng, Yan, Zhao, Yang, Wei, Zhai, Dongsheng, Wang, Li, Ye, Zichen, Lu, Huanyu, Xiang, An, Liang, Jingwei, Jiang, Yinghao, Xu, Chengming, Wang, Zhenyu, Wei, Ming, Lei, Xiaoying, Cao, Xiaorui, Lu, Zifan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845182/
https://www.ncbi.nlm.nih.gov/pubmed/29523188
http://dx.doi.org/10.1186/s13287-018-0771-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845182/
https://www.ncbi.nlm.nih.gov/pubmed/29523188
http://dx.doi.org/10.1186/s13287-018-0771-y

Ejemplares similares